Tempus AI, Inc. $TEM Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA trimmed its stake in shares of Tempus AI, Inc. (NASDAQ:TEM) by 11.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 389,067 shares of the company’s stock after selling 51,169 shares during the period. Massachusetts Financial Services Co. MA owned about 0.22% of Tempus AI worth $31,402,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the stock. Renaissance Capital LLC boosted its holdings in Tempus AI by 26.9% during the third quarter. Renaissance Capital LLC now owns 84,166 shares of the company’s stock worth $6,793,000 after buying an additional 17,866 shares in the last quarter. Pier 88 Investment Partners LLC purchased a new position in Tempus AI in the second quarter valued at $286,000. Blair William & Co. IL raised its position in shares of Tempus AI by 109.2% in the second quarter. Blair William & Co. IL now owns 67,637 shares of the company’s stock worth $4,298,000 after acquiring an additional 35,303 shares during the period. Trivium Point Advisory LLC raised its position in shares of Tempus AI by 670.7% in the second quarter. Trivium Point Advisory LLC now owns 38,627 shares of the company’s stock worth $2,454,000 after acquiring an additional 33,615 shares during the period. Finally, EFG Asset Management North America Corp. purchased a new stake in shares of Tempus AI during the 2nd quarter worth about $2,233,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on TEM. Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. HC Wainwright dropped their price objective on Tempus AI from $98.00 to $89.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Canaccord Genuity Group cut their price objective on Tempus AI from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Monday, December 22nd. Piper Sandler reduced their target price on Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. Finally, JPMorgan Chase & Co. decreased their target price on Tempus AI from $85.00 to $80.00 and set a “neutral” rating on the stock in a research report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Tempus AI presently has a consensus rating of “Hold” and an average price target of $87.20.

Tempus AI Trading Up 4.7%

Shares of Tempus AI stock opened at $68.36 on Friday. The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a twelve month low of $36.22 and a twelve month high of $104.32. The firm has a market capitalization of $12.16 billion, a PE ratio of -57.44 and a beta of 5.22. The firm’s 50-day moving average price is $68.94 and its 200 day moving average price is $73.63.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. The business had revenue of $334.21 million during the quarter, compared to analysts’ expectations of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The business’s revenue was up 84.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.46) earnings per share. On average, sell-side analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Activity

In related news, CEO Eric P. Lefkofsky sold 166,250 shares of the stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $63.99, for a total value of $10,638,337.50. Following the completion of the transaction, the chief executive officer directly owned 8,974,783 shares of the company’s stock, valued at approximately $574,296,364.17. This represents a 1.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Ryan Fukushima sold 5,000 shares of Tempus AI stock in a transaction on Monday, January 5th. The stock was sold at an average price of $64.26, for a total transaction of $321,300.00. Following the sale, the chief operating officer directly owned 148,808 shares in the company, valued at approximately $9,562,402.08. This trade represents a 3.25% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 932,832 shares of company stock valued at $71,184,024 in the last three months. Company insiders own 26.27% of the company’s stock.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.